KLK3 and benign prostatic hyperplasia: However, both PSA testing and DRE have limited specificity and sensitivity: DRE does not improve PSA-based detection [3], and PSA testing can be influenced by noncancerous conditions such as benign prostatic hyperplasia or inflammation [4], as well as by age.